0001140361-12-033010.txt : 20120712 0001140361-12-033010.hdr.sgml : 20120712 20120712185529 ACCESSION NUMBER: 0001140361-12-033010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120711 FILED AS OF DATE: 20120712 DATE AS OF CHANGE: 20120712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TISCH DANIEL R CENTRAL INDEX KEY: 0001111794 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23155 FILM NUMBER: 12960170 MAIL ADDRESS: STREET 1: 500 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP CENTRAL INDEX KEY: 0000911326 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 561808663 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: (781) 357-9900 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: SUITE 520 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: TRIMERIS INC DATE OF NAME CHANGE: 19970516 4 1 doc1.xml FORM 4 X0306 4 2012-07-11 0 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001111794 TISCH DANIEL R 500 PARK AVENUE NEW YORK NY 10022 0 0 1 0 Common Stock 2012-07-11 4 S 0 10000 45.725 D 215557 D Common Stock 167912 I Through trusts Common Stock 44750 I Through family partnership This statement is being filed solely for informational purposes because of family relationships. The filing of this statement is not an admission that the reporting person and any other person or persons constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934 or Rule 13d-5 thereunder or for any other purpose, and the reporting person disclaims beneficial ownership of any shares of the Issuer other than those reported herein. /s/ Daniel R. Tisch 2012-07-12